|
|
| Maladies Digestives > Etude de marché sectorielle |
| U.S. Gastrointestinal Pharmaceuticals OTC Market, 2004-2011 |
|
|
|
|
€ 80,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Mars 2006 |
Taille du document : |
1 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Diabetes Diagnostics
403 pages | Octobre 2005 |
This report analyzes the worldwide markets for Diabetes Diagnostics in Thousands of US$.
The major product segments analyzed are Blood Glucose Testing Devices, and Diabetes Testing Supplies.
The |
2 308,00 €
|
| |
| |
Antiulcerants Class Growth, 1991-2010
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
259 pages | Décembre 2004 |
IntroductionPancreatic adenocarcinoma is the fifth leading cancer-related cause of death and is thus a major health issue in the developed world.
Its aggressive nature and resistance to conventiona |
12 160,00 €
|
| |
| |
OTC Pharmaceuticals in China
151 pages | Novembre 2002 |
This new report on the market for over-the-counter (OTC) pharmaceuticals in the People’s Republic of China.
The report covers the following sectors: Analgesics, Cough, cold and allergy (hay-fever) |
1 065,00 €
|
| |
| |
UK Digestive Remedies 2004
14 pages | Juillet 2004 |
Snapdata's UK Digestive Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK digestive remedy market, |
240,00 €
|
| |
| |
OTC Digestive Remedies in France
15 pages | Septembre 2002 |
The French market for the OTC digestive remedies has grown by 0.2% since 2000 to reach a value of Euro296.2 million (US$272 million) in 2001.
Over the five year review period value sales slightly i |
198,00 €
|
| |
| |
Deals and alliances in gastrointestinal diseases
278 pages | Avril 2006 |
Partneringdesk deals and alliances in gastrointestinal diseases provides an in-depth view of over 240 deals and alliances announced in gastrointestinal diseases between 2001 and 2006, in a clear and a |
1 995,00 €
|
| |
| |
U.S. Market for Gastrointestinal Disorder Treatments, 2004-2012
1 pages | Octobre 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Commercial Insight: Antidyslipidemics - Cholesterol Absorption of Lipitor's Dominance
76 pages | Juin 2005 |
IntroductionThe next 10 years will see six statins lose patent protection, with the potential loss of over $20 billion across the seven major markets.
However, their established position as first-l |
12 160,00 €
|
| |
| |
Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
71 pages | Octobre 2005 |
IntroductionThe increase in diabetic kidney disease is a worldwide problem.
Current treatment centers on antihypertensives inhibitors for the renin-angiotensin system and merely retards the decline |
3 230,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| U.S. Gastrointestinal Pharmaceuticals OTC Market, 2004-2011 |
|
|
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
|
|
PPLSEN
|
|
|
|
|
